REACH 2026: What Cosmetics Manufacturers Must Act On Now
The first half of 2026 has compressed a significant volume of regulatory change into a short window. For cosmetics manufacturers, brand owners, and importers supplying the European market, the combined effect of updates under REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals), the EU Cosmetics Regulation (EC) No 1223/2009, and the June 2026 Omnibus VI political agreement creates a compliance landscape that demands active, ongoing monitoring — not a once-a-year audit.
This brief maps the substantive changes and their practical implications for regulatory and quality teams.
New Prohibitions and Restrictions Already in Force
Two significant instrument updates have already taken effect in 2026, and compliance teams that have not yet reviewed their product portfolios against both are at immediate risk.
Regulation (EU) 2026/78 — Omnibus VIII (effective 1 May 2026)
The Commission's Omnibus VIII act introduced 18 new substances to the restricted or prohibited ingredients lists under the EU Cosmetics Regulation. These substances were reclassified as CMR (carcinogenic, mutagenic, or reprotoxic) through updates to the EU's Classification, Labelling and Packaging (CLP) Regulation, which under the Cosmetics Regulation triggers automatic restriction or prohibition. Any product formulated with these substances that was placed on the EU market on or after 1 May 2026 must comply. Products already on market were subject to a brief transitional window; that window has closed for the majority of affected substances.
Regulation (EU) 2026/909 (in force from May 2026)
This regulation amends the Annexes of Regulation 1223/2009 with several notable changes:
- Triphenyl phosphate has been added to Annex II (prohibited substances), driven by its classification as an endocrine disruptor. Any cosmetic product — including nail products and plasticiser-containing formulations — containing triphenyl phosphate is prohibited on the EU market.
- Benzyl salicylate and citral now carry revised, tighter concentration limits in leave-on and rinse-off products. Both are fragrance allergens and their new limits must be assessed alongside the July 2026 fragrance allergen labelling changes.
- Aluminium in antiperspirant and lip product categories is subject to new maximum concentration limits reflecting updated SCCS (Scientific Committee on Consumer Safety) opinions on systemic exposure.
- Multiple hair dye ingredients — including specific HC Blue, HC Yellow, and HC Red variants — face new restrictions or outright bans following adverse classification assessments.
- DHHB (a UV filter listed under Annex VI) is subject to revised conditions of use.
Manufacturers supplying the EU market with any of these ingredient categories must verify their current formulations and concentration calculations against the updated Annex text, not against the pre-2026 regulatory baseline.
REACH SVHC Candidate List: February and June 2026 Updates
The Substances of Very High Concern (SVHC) Candidate List, maintained by ECHA, is updated twice yearly and triggers immediate supply chain obligations upon addition — without waiting for formal restriction under REACH Annex XVII or authorisation requirements to be established.
The February 2026 update added n-hexane and Bisphenol AF (4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol). The June 2026 update added three further substances, including a fluorinated resin curing agent and two nano-scale coupling agents.
When a substance is added to the SVHC Candidate List, the obligations are specific and time-sensitive:
- Customer communication: If an article contains an SVHC above 0.1% w/w, the downstream customer must be informed — and consumers must be informed upon request — within 45 days of addition.
- SCIP database notification: Suppliers of articles containing SVHCs above 0.1% must submit a notification to ECHA's SCIP (Substances of Concern in Products) database.
- Safety Data Sheet (SDS) updates: Suppliers of substances or mixtures that include newly listed SVHCs must update their SDS accordingly.
For cosmetics manufacturers, the most relevant trigger is the 0.1% threshold in any article — including packaging components, which are also subject to SVHC communication obligations even when the cosmetic product itself may be exempt as a mixture.
PFAS: October 2026 Deadline Approaching
Under REACH Annex XVII, transitional arrangements for PFHxA (perfluorohexanoic acid) and its salts are concluding. From 10 October 2026, these substances — along with PFHxA-related substances — may not be placed on the EU market above specified concentration limits (≥25 ppb for PFHxA and its salts in mixtures, lower for certain use categories). Cosmetic formulations that use PFAS-derived ingredients for texture, water resistance, or film-forming performance must be assessed against the finalised restriction parameters.
Additionally, the broader PFAS restriction under REACH continues to develop. ECHA published a universal PFAS restriction proposal in 2023, and while the final regulatory outcome is still being processed through the assessment pipeline, the direction of travel — towards comprehensive restriction on most non-essential PFAS uses — is established. Manufacturers still using any PFAS-derived functional ingredient should have active substitution programmes in place.
Omnibus VI: Structural Reform with Forward Implications
On 17 June 2026, the Council of the EU and European Parliament reached a political agreement on the Omnibus VI package — a legislative simplification initiative that amends the EU Cosmetics Regulation and the CLP Regulation simultaneously. The key provisions that affect cosmetics manufacturers:
- Accelerated CMR phase-out timelines: Once a CMR ban enters into force, companies will have six months to stop placing affected products on the market and 12 months to withdraw existing stock. This compresses the current transitional periods significantly and means that CMR-related formulation contingency planning must begin at the point of scientific opinion, not at the point of formal restriction.
- Nanomaterials notification reinstated: The pre-market notification requirement for cosmetics containing nanomaterials — previously suspended for administrative simplification — is being reinstated under Omnibus VI, though the original 6-month advance notice requirement has been removed.
- CLP application date deferred: The revised CLP Regulation application date has been postponed to 1 January 2030, easing reclassification-triggered compliance pressure in the short term.
- Substitution guidance mandate: The European Commission must develop guidance on substitution analysis for hazardous substances within one year of Omnibus VI's entry into force — signalling a more structured approach to hazardous ingredient replacement.
Practical Steps for Compliance Teams
The current regulatory environment requires a multi-track response, not sequential action. The following priorities should be running in parallel:
- Run a formulation screen against the May 2026 updates immediately. If your products contain triphenyl phosphate, any of the 18 newly prohibited CMR substances from Omnibus VIII, or revised-limit allergens (benzyl salicylate, citral), your formulation and labelling compliance for EU-destined product is at immediate risk.
- Pull the June 2026 SVHC Candidate List and cross-reference your ingredient list and packaging materials. The communication and SCIP obligations are triggered immediately on addition — there is no grace period.
- Begin PFAS inventory audit now, ahead of October 2026. If any formulation or packaging component contains PFHxA or related substances, assess against the October 2026 concentration limits.
- Brief your formulation team on Omnibus VI's accelerated CMR timeline. The 6-month stop-market, 12-month withdrawal clock means proactive reformulation for substances under SCCS scientific assessment is now a business continuity priority, not a future planning item.
- Update Safety Data Sheets for all affected raw materials. Suppliers should be issuing updated SDS following the June SVHC addition — request these proactively and confirm integration into your technical dossiers.
For Indian manufacturers exporting to the EU, or supplying EU-based importers with finished products or raw materials, all of these obligations apply at the point of EU market entry. The responsible person in the EU carries the formal compliance obligation, but the upstream data quality — formulation transparency, allergen quantification, SVHC-free declarations — must originate with the manufacturer.